Seventeen Americans are spending their days inside sealed quarantine rooms in Omaha, Nebraska, waiting to find out whether a virus they may have been exposed to on an Antarctic cruise ship will make them gravely ill. Three of their fellow passengers are already dead.
The travelers had been aboard the M/V Hondius, a polar expedition vessel operated by Dutch company Oceanwide Expeditions, when an outbreak of Andes virus tore through the ship. Andes virus is a hantavirus, and based on documented evidence to date, it is the only one known to spread directly from person to person. That distinction turned what began as a small cluster of febrile illness on a cruise into an international public health emergency.
In May 2026, the U.S. Department of Health and Human Services coordinated a medical airlift to bring the 17 Americans home. They were taken to the University of Nebraska Medical Center, which houses one of the country’s few federally designated biocontainment facilities. Some are being held in UNMC’s National Quarantine Unit for observation. Others, either symptomatic or considered higher risk, were placed in the separate Nebraska Biocontainment Unit, where clinical teams are trained to manage high-consequence infections. A smaller group of exposed individuals is being evaluated at Emory University Hospital in Atlanta, which operates its own serious-communicable-disease unit.
Because Andes virus can incubate for anywhere from roughly four days to as long as six weeks before symptoms appear, according to the CDC’s health advisory on the Hondius cluster, every one of these travelers faces an extended stretch of daily temperature checks, respiratory assessments, and periodic blood draws before doctors can be confident they are in the clear.
What investigators have confirmed so far
The World Health Organization, in a disease outbreak bulletin dated May 8, confirmed seven cases and three deaths tied to the Hondius cluster. All confirmed infections were identified as Andes virus through PCR testing and genomic sequencing. The clinical pattern has been alarming: patients initially developed fever and gastrointestinal symptoms that, in the most severe cases, escalated rapidly to pneumonia, acute respiratory distress syndrome, and cardiovascular shock. Published medical literature places the case fatality rate for Andes virus hantavirus pulmonary syndrome at roughly 30 to 40 percent.
The HHS statement described the medical evacuation as a precautionary measure to place repatriated travelers in “secure care and observation settings designed for high-consequence pathogens.” The CDC followed with a formal health advisory classifying the situation as a new multi-country cluster and urging clinicians across the United States to watch for compatible symptoms in anyone connected to the Hondius itinerary.
In that advisory, the agency noted that person-to-person transmission of Andes virus, while uncommon, has been documented in prior outbreaks in southern Argentina and Chile, most notably a 1996 cluster in the Patagonian town of El Bolson that was later described in Argentine epidemiological studies as one of the first confirmed instances of interpersonal hantavirus spread. Transmission appears to require close physical contact, prolonged time in enclosed spaces, or direct exposure to an infected person’s respiratory secretions or body fluids. Casual encounters, the CDC stressed, do not appear to pose a meaningful risk, and the agency said the threat to the broader American public remains “extremely low.”
“We are treating this with an abundance of caution,” a UNMC spokesperson told reporters during a May 2026 briefing, adding that the medical center’s biocontainment team is staffed around the clock to monitor the quarantined travelers and coordinate with federal health agencies on testing protocols.
The European Centre for Disease Prevention and Control, in its own rapid risk assessment, concluded that the initial exposure most likely occurred during shore excursions in Argentine Patagonia, where Andes virus circulates in wild long-tailed pygmy rice rats and other native rodent species. The Hondius, which can carry approximately 170 passengers, had departed from Ushuaia, Argentina, on an Antarctic itinerary that included multiple land-based stops in the region.
Investigators are now trying to determine whether one or more passengers who picked up the virus on land then transmitted it to fellow travelers inside the ship’s cabins, dining rooms, or shared recreational spaces. Published Argentine epidemiological research, including studies of the 1996 El Bolson outbreak, has documented so-called super-spreader events in past Andes virus chains, where a single infected person generated a disproportionate number of secondary cases. Those findings are shaping the epidemiological models being applied to the Hondius cluster.
The questions no one has answered yet
For all the information that has been released, several critical gaps remain.
U.S. officials have not disclosed how many of the 17 repatriated Americans have actually tested positive for Andes virus versus how many are in quarantine purely as close contacts. The HHS announcement and subsequent briefings cited only the total number of transported passengers, leaving the public without a clear picture of how many are sick and how many are simply waiting to find out.
The precise chain of transmission aboard the ship is also unresolved. European health authorities have described person-to-person spread on the Hondius as plausible but not yet proven. Contact tracing is being coordinated through the International Health Regulations mechanism, with investigators reconstructing cabin assignments, meal seatings, group excursion rosters, and any documented episodes of close contact with symptomatic passengers. No agency has publicly addressed whether the ship’s ventilation system, housekeeping protocols, or the layout of common areas may have amplified exposure risk.
Equally unclear is whether any crew members became infected. Cruise staff routinely move between multiple cabins and public spaces throughout a voyage. An infected crew member could have created exposure links across decks and passenger groups that would be difficult to trace after the fact.
Weeks of waiting inside biocontainment
For the Americans now inside UNMC and Emory, the coming weeks will be defined by uncertainty. Asymptomatic travelers will be checked daily for fever, cough, shortness of breath, and other early signs of hantavirus cardiopulmonary syndrome. Periodic blood draws will test for viral RNA and rising antibody levels. Anyone who develops symptoms consistent with Andes virus infection will be moved into, or maintained within, higher-level biocontainment, where clinicians can deliver intensive supportive care. That means mechanical ventilation and careful fluid management, the mainstays of hantavirus treatment in the absence of a proven antiviral drug.
Extended isolation of up to six weeks also carries a psychological toll. UNMC’s biocontainment program, which gained national attention during the 2014 Ebola response, integrates mental health professionals, social workers, and chaplains into its care teams specifically to address the stress, uncertainty, and loneliness that accompany prolonged quarantine. Similar support structures are in place at Emory.
Why the Hondius results will shape expedition cruise health rules
What happens to these 17 travelers will shape public health guidance well beyond the Hondius voyage. If few or none of the close contacts develop disease over the monitoring period, it would reinforce the understanding that even Andes virus requires very specific, sustained conditions to jump between people. If additional confirmed cases emerge among the quarantined group, it would strengthen the case that the ship’s enclosed environment enabled a transmission chain, a finding that could prompt new infection-control standards for expedition cruise lines operating in regions where the virus is endemic.
Laboratory results, contact-tracing data, and clinical outcomes will continue to arrive through June 2026. The CDC, WHO, and ECDC have all indicated they will update their risk assessments as new information becomes available. For now, the response hinges on the same calculation that drove the airlift in the first place: contain early, monitor closely, and treat aggressively if the virus surfaces again.
